Precision BioSciences has grand regulatory ambitions for its lead program: first allogeneic CAR-T therapy on the market. En route to meeting with the FDA later this year on potential registration strategy, the North Carolina biotech is out with new interim Phase I/IIa clinical data on its prized possession, dubbed PBCAR0191. The anti-CD19 candidate is being […]
Tag Archives: approval
Jan 10 (Reuters) – Swiss drugmaker Idorsia (IDIA.S) said on Monday it has received the U.S. Food and Drug Administration’s approval for its treatment for insomnia in adult patients. The drug, to be available under the brand name Quviviq, was approved in doses of 25 mg and 50 mg based on data from two late-stage […]